90
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES Clinical Translational Therapeutics

Strategies to Decrease Taxanes Toxicities in the Adjuvant Treatment of Early Breast Cancer

Pages 206-214 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Laura Cabeza, Raúl Ortiz, José L Arias, Jose Prados, Maria Adolfina Ruiz Martínez, José M Entrena, Raquel Luque & Consolación Melguizo. (2015) Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles. International Journal of Nanomedicine 10, pages 1291-1306.
Read now
Alvin Eisner & Shiuh-Wen Luoh. (2011) Breast Cancer Medications and Vision: Effects of Treatments for Early-stage Disease. Current Eye Research 36:10, pages 867-885.
Read now

Articles from other publishers (7)

Yi-Jing Li, Jia-Qi Wang, Wen Tian, Lu Han, Ting Xiao, Xiu-Hai Wu, Lei Wang, Pei-Pei Yang, Hui Cao, Wan-Hai Xu & Hao Wang. (2023) An adhesive peptide specifically induces microtubule condensation. Materials Horizons 10:11, pages 5298-5306.
Crossref
Lei Lei, Xiao-Jia Wang & Shou-Ching Tang. (2022) Novel taxanes in development: Hopes or hypes?. Critical Reviews in Oncology/Hematology 176, pages 103727.
Crossref
Vahideh Alinejad, Mohammad Hossein Somi, Behzad Baradaran, Parvin Akbarzadeh, Fatemeh Atyabi, Hanif Kazerooni, Hosein Samadi Kafil, Leili Aghebati Maleki, Homayoon Siah Mansouri & Mehdi Yousefi. (2016) Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells. Biomedicine & Pharmacotherapy 83, pages 229-240.
Crossref
Shuzhen Liu, Judy-Anne W. Chapman, Margot J. Burnell, Mark N. Levine, Kathleen I. Pritchard, Timothy J. Whelan, Hope S. Rugo, Kathy S. Albain, Edith A. Perez, Shakeel Virk, Garrett Barry, Dongxia Gao, Patti O’Brien, Lois E. Shepherd, Torsten O. Nielsen & Karen A. Gelmon. (2015) Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial. Breast Cancer Research and Treatment 149:2, pages 439-448.
Crossref
Rita De Sanctis, Silvia Quadrini, Flavia Longo, Vittoria Lapadula, Rossella Restuccia, Ester Del Signore, Lucilla De Filippis, Luciano Stumbo, Bruno Gori, Vincenzo Bianco, Iolanda Speranza, Maria Luisa Basile & Marisa Di Seri. (2018) Capecitabine in Elderly Patients with Metastatic Breast Cancer. Tumori Journal 98:3, pages 303-307.
Crossref
Ana R. Rama, Jose Prados, Consolacion Melguizo, Miguel Burgos, Pablo J. Alvarez, Fernando Rodriguez-Serrano, Juan L. Ramos & A. Aranega. (2011) Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells. Biomedicine & Pharmacotherapy 65:4, pages 260-270.
Crossref
Jose Prados, Consolación Melguizo, Ana Rosa Rama, Rául Ortiz, Ana Segura, Houria Boulaiz, Celia Vélez, Octavio Caba, Juan Luís Ramos & Antonia Aránega. (2009) Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells. Cancer Chemotherapy and Pharmacology 66:1, pages 69-78.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.